Copyright Reports & Markets. All rights reserved.

Dynamics in Post-pandemic Global Antimicrobial Peptides Industry: Supply and Demand, Markets and Prices 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Antimicrobial Peptides Market Status and Forecast (2016-2027)
      • 1.3.2 Global Antimicrobial Peptides Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Antimicrobial Peptides Supply by Company

    • 2.1 Global Antimicrobial Peptides Sales Volume by Company
    • 2.2 Global Antimicrobial Peptides Sales Value by Company
    • 2.3 Global Antimicrobial Peptides Price by Company
    • 2.4 Antimicrobial Peptides Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Antimicrobial Peptides Market Status by Category

    • 3.1 Antimicrobial Peptides Category Introduction
      • 3.1.1 Plant Antimicrobial Peptides
      • 3.1.2 Microbial Antimicrobial Peptides
      • 3.1.3 Animal Antimicrobial Peptides
    • 3.2 Global Antimicrobial Peptides Market by Category
      • 3.2.1 Global Antimicrobial Peptides Sales Volume by Category (2016-2021)
      • 3.2.2 Global Antimicrobial Peptides Sales Value by Category (2016-2021)
      • 3.2.3 Global Antimicrobial Peptides Price by Category (2016-2021)
    • 3.3 North America: by Category
    • 3.4 Europe: by Category
    • 3.5 Asia Pacific: by Category
    • 3.6 Central & South America: by Category
    • 3.7 Middle East & Africa: by Category

    4 Global and Regional Antimicrobial Peptides Market Status by End User/Segment

    • 4.1 Antimicrobial Peptides Segment by End User/Segment
      • 4.1.1 Pharmaceuticals
      • 4.1.2 Feed Additives
      • 4.1.3 Others
    • 4.2 Global Antimicrobial Peptides Market by End User/Segment
      • 4.2.1 Global Antimicrobial Peptides Sales Volume by End User/Segment (2016-2021)
      • 4.2.2 Global Antimicrobial Peptides Sales Value by End User/Segment (2016-2021)
      • 4.2.3 Global Antimicrobial Peptides Price by End User/Segment (2016-2021)
    • 4.3 North America: by End User/Segment
    • 4.4 Europe: by End User/Segment
    • 4.5 Asia Pacific: by End User/Segment
    • 4.6 Central & South America: by End User/Segment
    • 4.7 Middle East & Africa: by End User/Segment

    5 Global Antimicrobial Peptides Market Status by Region

    • 5.1 Global Antimicrobial Peptides Market by Region
      • 5.1.1 Global Antimicrobial Peptides Sales Volume by Region
      • 5.1.2 Global Antimicrobial Peptides Sales Value by Region
    • 5.2 North America Antimicrobial Peptides Market Status
    • 5.3 Europe Antimicrobial Peptides Market Status
    • 5.4 Asia Pacific Antimicrobial Peptides Market Status
    • 5.5 Central & South America Antimicrobial Peptides Market Status
    • 5.6 Middle East & Africa Antimicrobial Peptides Market Status

    6 North America Antimicrobial Peptides Market Status

    • 6.1 North America Antimicrobial Peptides Market by Country
      • 6.1.1 North America Antimicrobial Peptides Sales Volume by Country (2016-2021)
      • 6.1.2 North America Antimicrobial Peptides Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Antimicrobial Peptides Market Status

    • 7.1 Europe Antimicrobial Peptides Market by Country
      • 7.1.1 Europe Antimicrobial Peptides Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Antimicrobial Peptides Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Antimicrobial Peptides Market Status

    • 8.1 Asia Pacific Antimicrobial Peptides Market by Country
      • 8.1.1 Asia Pacific Antimicrobial Peptides Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Antimicrobial Peptides Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Antimicrobial Peptides Market Status

    • 9.1 Central & South America Antimicrobial Peptides Market by Country
      • 9.1.1 Central & South America Antimicrobial Peptides Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Antimicrobial Peptides Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Antimicrobial Peptides Market Status

    • 10.1 Middle East & Africa Antimicrobial Peptides Market by Country
      • 10.1.1 Middle East & Africa Antimicrobial Peptides Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Antimicrobial Peptides Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Sales Channel, Distributors and Buyers

    • 11.1 Sales Channel
      • 11.1.1 Direct Sales
      • 11.1.2 Channel Sales
    • 11.2 Antimicrobial Peptides Distributors
    • 11.3 Antimicrobial Peptides Buyers

    12 Global Antimicrobial Peptides Market Forecast by Category and by End User/Segment

    • 12.1 Global Antimicrobial Peptides Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Antimicrobial Peptides Forecast by Category
      • 12.2.1 Global Antimicrobial Peptides Sales Volume Forecast by Category
      • 12.2.2 Global Antimicrobial Peptides Sales Value Forecast by Category
      • 12.2.3 Global Antimicrobial Peptides Price Forecast by Category
    • 12.3 Global Antimicrobial Peptides Forecast by End User/Segment
      • 12.3.1 Global Antimicrobial Peptides Sales Volume Forecast by End User/Segment
      • 12.3.2 Global Antimicrobial Peptides Sales Value Forecast by End User/Segment
      • 12.3.3 Global Antimicrobial Peptides Price Forecast by End User/Segment

    13 Global Antimicrobial Peptides Market Forecast by Region/Country

    • 13.1 Global Antimicrobial Peptides Market Forecast by Region (2022-2027)
      • 13.1.1 Global Antimicrobial Peptides Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Antimicrobial Peptides Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 AnaSpec
      • 14.1.1 Company Information
      • 14.1.2 Antimicrobial Peptides Product Introduction
      • 14.1.3 AnaSpec Antimicrobial Peptides Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 Contact Information
    • 14.2 AMP Biotech
      • 14.2.1 Company Information
      • 14.2.2 Antimicrobial Peptides Product Introduction
      • 14.2.3 AMP Biotech Antimicrobial Peptides Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 Contact Information
    • 14.3 Hycult Biotech
      • 14.3.1 Company Information
      • 14.3.2 Antimicrobial Peptides Product Introduction
      • 14.3.3 Hycult Biotech Antimicrobial Peptides Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 Contact Information
    • 14.4 Ruixing Biotechnology
      • 14.4.1 Company Information
      • 14.4.2 Antimicrobial Peptides Product Introduction
      • 14.4.3 Ruixing Biotechnology Antimicrobial Peptides Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 Contact Information
    • 14.5 Glam Technology
      • 14.5.1 Company Information
      • 14.5.2 Antimicrobial Peptides Product Introduction
      • 14.5.3 Glam Technology Antimicrobial Peptides Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 Contact Information
    • 14.6 Sunsmile
      • 14.6.1 Company Information
      • 14.6.2 Antimicrobial Peptides Product Introduction
      • 14.6.3 Sunsmile Antimicrobial Peptides Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 Contact Information
    • 14.7 Novabiotics
      • 14.7.1 Company Information
      • 14.7.2 Antimicrobial Peptides Product Introduction
      • 14.7.3 Novabiotics Antimicrobial Peptides Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.7.4 Contact Information
    • 14.8 Ontores
      • 14.8.1 Company Information
      • 14.8.2 Antimicrobial Peptides Product Introduction
      • 14.8.3 Ontores Antimicrobial Peptides Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.8.4 Contact Information
    • 14.9 Phoenix Biotech
      • 14.9.1 Company Information
      • 14.9.2 Antimicrobial Peptides Product Introduction
      • 14.9.3 Phoenix Biotech Antimicrobial Peptides Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.9.4 Contact Information
    • 14.10 Zhongnong Yingtai Biotechnology
      • 14.10.1 Company Information
      • 14.10.2 Antimicrobial Peptides Product Introduction
      • 14.10.3 Zhongnong Yingtai Biotechnology Antimicrobial Peptides Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.10.4 Contact Information
    • 14.11 Chinese Peptide
    • 14.12 GenScript

    15 Conclusion

    Covid-19 has impacted the supply and demand status for many industries along the supply chain. In this report a comprehensive analysis of current global Antimicrobial Peptides market in terms of demand and supply environment is provided, as well as price trend currently and in the next few years. This report also includes global and regional market size and forecast, major product development trend and typical downstream segment scenario, under the context of market drivers and inhibitors analysis. According to this survey, the global Antimicrobial Peptides market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million in 2027.

    Segmented by Category
    Plant Antimicrobial Peptides
    Microbial Antimicrobial Peptides
    Animal Antimicrobial Peptides

    Segmented by End User/Segment
    Pharmaceuticals
    Feed Additives
    Others

    Segmented by Country
    North America
    United States
    Canada
    Mexico
    Europe
    Germany
    France
    UK
    Italy
    Russia
    Spain
    Asia Pacific
    China
    Japan
    Korea
    Southeast Asia
    India
    Australasia
    Central & South America
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Iran
    Israel
    Turkey
    South Africa
    Saudi Arabia

    Key manufacturers included in this survey
    AnaSpec
    AMP Biotech
    Hycult Biotech
    Ruixing Biotechnology
    Glam Technology
    Sunsmile
    Novabiotics
    Ontores
    Phoenix Biotech
    Zhongnong Yingtai Biotechnology
    Chinese Peptide
    GenScript
    Buy now